Nanoview Biosciences Company
nanoView Diagnostics Inc. (dba NanoView Biosciences), is developing proprietary products that support research, translation and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Our high-throughput, cost-effective analysis solutions enable life science researchers to better understand the biological role of exosomes and how to utilize them as biomarkers to provide improved insight for how diseases are diagnosed, treated and monitored.
Founded Date:
2015-01-01
Total Funding:
21850000
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
Other
Last Funding Type:
Series B
Investors Number:
5
Industry:
P4 Medicine
Headquarters:
Boston, Massachusetts, United States
Estimated Revenue:
$1M to $10M